Oxford Immunotec Global Plc's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the third quarter 2020 to a ratio of 4.39, above the company average. This is a clear sign of healthy business climate in the In Vitro & In Vivo Diagnostic Substances industry and improving liquidity at their respective customers, during the third quarter 2020. Average receivable collection period, for the Oxford Immunotec Global Plc in Sep 30 2020 quarter, has decreased to 83 days, compared to 101 days, in the Jun 30 2020 quarter.

If we take a look into Healthcare sector 372 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 2694, from overall ranking in the second quarter 2020 at 2917.

What is Receivable Turnover Ratio?
What is Oxford Immunotec Global Plc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

OXFD Receivables Turnover Ratio	(Sep 30 2020) III. Quarter	(Jun 30 2020) II. Quarter	(Mar 31 2020) I. Quarter	(Dec 31 2019) IV. Quarter	(Sep 30 2019) III. Quarter
Y / Y Receivable Change	-54.32 %	-78.77 %	21.78 %	34.2 %	241.69 %
Y / Y Revenue Change	-8.4 %	-70.21 %	-5.94 %	-	32.21 %
Receivable Turnover Ratio (TTM)	4.39	3.62	3.5	3.68	2.58
OXFD's Total Ranking	# 2694	# 2917	# 2916	# 2474	# 2919
Accounts Receivable average collection period days	83	101	104	99	142
Seq. Receivable Change	127.32 %	-72.87 %	-2.23 %	-24.24 %	5.67 %
Seq. Revenue Change	233.09 %	-58.05 %	-23.2 %	-14.63 %	8.33 %

Receivable Turnover Company Ranking
Within:	No.
In Vitro & In Vivo Diagnostic Substances Industry	# 11
Healthcare Sector	# 373
Overall Market	# 2694

Receivable Turnover Ratio Statistics
High	Average	Low
0.91	0.55	0.2
(Sep 30 2017)		(Sep 30 2019)

OXFD Company Profile • Back to OXFD Efficiency Comparisons • Compare OXFD Receivables Turnover Ratio to its Competitors

Financial Statements
Oxford Immunotec Global Plc's Accounts Receivable	$ 11 Millions	Visit OXFD's Balance sheet
Oxford Immunotec Global Plc's Sales TTM	$ 57 Millions	Visit OXFD's Income Statement
Sources of OXFD's Revenues		Visit OXFD's Sales by Geography

Other Accounts Receivable Turnover Ratios
In Vitro & In Vivo Diagnostic Substances Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
OXFD's Receivable Turnover Ratio versus In Vitro & In Vivo Diagnostic Substances Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
OXFD's Growth Rates	OXFD's Roa	OXFD's Inventory Turnover Ratio	OXFD's Dividend Comparisons
OXFD's Profitability Ratios	OXFD's Roi	OXFD's Asset Turnover Ratio	OXFD's Dividend Growth
OXFD's Valuation Ratios	OXFD's Roe	OXFD's Financial Strength Ratios	OXFD's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2020, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Sep 30 2020	Receivable at quarter ending Sep 30 2020
Ibio inc	14.19	$ 1.940 Millions	$ 0.137 Millions
Benitec Biopharma Inc	13.61	$ 0.262 Millions	$ 0.019 Millions
Dmk Pharmaceuticals Corporation	13.51	$ 18.430 Millions	$ 1.365 Millions
Musclepharm Corporation	13.17	$ 66.727 Millions	$ 5.067 Millions
Sqz Biotechnologies Company	12.94	$ 6.121 Millions	$ 0.473 Millions
Patterson Companies Inc	12.80	$ 5,541.621 Millions	$ 432.946 Millions
Crispr Therapeutics Ag	12.20	$ 77.365 Millions	$ 6.340 Millions
Electrocore Inc	12.19	$ 3.243 Millions	$ 0.266 Millions
Immucell Corporation	12.06	$ 18.201 Millions	$ 1.510 Millions
Travere Therapeutics Inc	11.90	$ 194.026 Millions	$ 16.309 Millions
Prothena Corporation Public Limited Company	11.89	$ 0.749 Millions	$ 0.063 Millions
Rayont Inc	11.86	$ 1.559 Millions	$ 0.131 Millions
Teladoc Health Inc	11.82	$ 848.610 Millions	$ 71.774 Millions
Sunlink Health Systems Inc	11.70	$ 57.954 Millions	$ 4.954 Millions
Integrated Biopharma Inc	11.59	$ 56.535 Millions	$ 4.878 Millions
American Bio Medica Corporation	11.48	$ 4.249 Millions	$ 0.370 Millions
Alpha Pro Tech Ltd	11.22	$ 84.600 Millions	$ 7.538 Millions
Harmony Biosciences Holdings inc	11.17	$ 45.609 Millions	$ 4.082 Millions
Dariohealth Corp	11.17	$ 7.294 Millions	$ 0.653 Millions
Co diagnostics Inc	11.06	$ 47.516 Millions	$ 4.294 Millions
National Healthcare Corp	11.05	$ 1,022.272 Millions	$ 92.491 Millions
Option Care Health Inc	10.91	$ 3,551.961 Millions	$ 325.689 Millions
Adamas Pharmaceuticals Inc	10.83	$ 69.799 Millions	$ 6.443 Millions
Intellia Therapeutics Inc	10.81	$ 62.335 Millions	$ 5.767 Millions
Scienture Holdings Inc	10.77	$ 16.824 Millions	$ 1.562 Millions
Insulet Corporation	10.64	$ 867.694 Millions	$ 81.575 Millions
Clearpoint Neuro Inc	10.52	$ 12.323 Millions	$ 1.172 Millions
Allied Healthcare Products inc	10.48	$ 34.108 Millions	$ 3.255 Millions
Strongbridge Biopharma plc	10.45	$ 28.111 Millions	$ 2.690 Millions
Regeneron Pharmaceuticals Inc	10.27	$ 8,243.700 Millions	$ 802.400 Millions

Date modified: 2026-06-22T16:30:25+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.